INDEX S.NO 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 CONTENT COMPANY OVERVIEW PRODUCT OVERVIEW FACTORS AFFECTING SUPPLY FACTORS AFFECTING DEMAND MARKET SURVEY RESPONSE OF CONSUMER OBSERVVATION DEMAND SCHEDULE TYPE OF COMPETITION FORM OF MARKET STRUCTURE SHORT RUN EQUILIBRIUM LONG RUN EQUILIBRIUM LEVEL OF BARRIERS AFFECT ON PRICE STRATEGY FINANCIAL STATEMENT PAGE NO 3 6 8 10 12 13 14 15 16 17 18 19 20 22 23 16 17 CSR BIBLIOGRAPHY 29 34 K V Kamoth.952 ( USD in Millions ) 161393. Marc Desaedeleer. M D Gupta. Nilesh Gupta. K V Kamath. DeshBandhu Gupta.894597 ( Rs. Maharashtra www.KalinaSantacruz (East). Mumbai-400098.lupinworld.D K Contractor. Kamal K Sharma.com Chairperson .DeshBandhu Gupta MD . in Millions ) 159 C S T Road.Company Overview Date of Establishment Revenue Market Cap BnCorporate Address 1983 580.Kamal K Sharma Directors . K U Mada. Management Details . generic and branded formulations. It has onshore and offshore presence of its products in 70 countries. It is the largest manufacturer of Tuberculosis drugs in the world.R A Shah. Indore. Tarapur. Jammu. R V Satam. Vinita Gupta Business operationBackground Pharmaceuticals & Drugs Lupin is a transnational company engaged in development of APIs. Ankleshwar. Mandideep. Sunil Nair. Vijay Kelkar. Its manufacturing unit is located in Goa. . Richard Zahn. Key excutive S.No 1 3 2 4 5 6 7 8 9 10 11 12 13 14 15 Name DeshBandhu Gupta Kamal K Sharma R V Satam D K Contractor Vinita Gupta K U Mada R A Shah M D Gupta Nilesh Gupta Vijay Kelkar K V Kamoth Richard Zahn K V Kamath Vijay Kelkar Richard Zahn Designation Chairman Managing Director Company Secretary Director Director Director Director Executive Director Executive Director Additional Director Additional Director Additional Director Independent Director Independent Director Independent Director . Lupin Pharmaceuticals. Today. Asthma. Pediatrics. The Company¶s foray into Advanced Drug Delivery Systems has resulted in the development of platform technologies that are being used to develop value-added generic pharmaceuticals.S (ranked 8th by prescriptions & growing at 50 %) and Japan (ranked 7th and growing at 23%). CNS. Headquartered in Baltimore. The company is also the fastest growing. affordable generic medicines and branded formulations trusted by healthcare professionals and patients across geographies.lupinworld. not to mention global leadership positions in the Anti-TB and Cephalosporins. visithttp://www. Diabetology. affordable generic and branded formulations and APIs for the developed and developing markets of the world. Maryland. For more information.S. Lupin's Consolidated Revenues and Profit after Tax were Rs. 5015 million (US$ 109 million) respectively. is dedicated to delivering high-quality. The Company today has significant market share in key markets in the Cardiovasculars (prils and statins). Inc. top 5 pharmaceutical players in India (ORG IMS . India.INTRODUCTION OF LUPIN PHARMA About Lupin Headquartered in Mumbai. The Company¶s R&D endeavors have resulted in significant progress in its NCE program. wholly owned subsidiary of Lupin Ltd. Our Drugs and products reach over 70 countries in the world.39. Lupin has the unique distinction of being the fastest growing top 10 Generics players in the two largest pharmaceutical markets of the world ± The U.145 million (US$ 851 million) and Rs. Anti-Infectives and NSAIDs therapy segments. Please visit http://www. . Lupin Pharmaceuticals.March 2009) and the fastest growing Generic player in South Africa (ranked 6th and growing at 36 % YoY .com. Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality.IMS) For the financial year ended March 2009.lupinpharmaceuticals.com for more information about Lupin Ltd. is the U. Inc. GI. which has enabled the Company to attain market leadership in the Anti-TB segment of IPM. Key Products : LupinPharma Product R-Cinex AKT Akurit R-CIN G-CIN Combutol Pyzina Therapeutic segment Anti-TB Anti-TB Anti-TB Anti-TB Gemifloxacin Ethambutol& Comb. Pyrazinamide Plain Product Rank in the relevant segment 1 1 1 1 1 1 2 . Lupin has embarked on an effort which would redefine the treatment guidelines based on conditions existing in India under the aegis of RIETT-Redefining Indian Expertise Based Tuberculosis Treatment.3.162mn Anti-TB market. Lupin commands 48% of the market share. As market leaders in this space. In a Rs.LupinPharma The Company¶s concerted focus on the semi-acute therapy is the crux of the Lupin division. 69 34.30 17.91 2271/1086 161393.60 16.62 48392.67 45025.15 53.22 3.60 11905.09 1846/1070 254164.95 -3.00 882.06 -1.22 0.49 26.84 104997.14 -1.00 16.78 10.00 47802.60 538.(Rs.92 27796.27 29.16 7.41 3.92 9744.50 19794.00 91.50 49606.03 24.53 31288.76 221305.77 16718.31 363/211 1335/598 538/217 173149.87 24.16 39.90 22.60 5763.08 0.57 19.00 500.80 4158.71 27.84 20732.00 129.35 1050.42 3.89 32.00 0.59 9123.40 11783.81 3965.38 0.44 12956. Glaxosmithkline Phar Lupin Cadila Healthcare Piramal Healthcare Divi'S Lab GlenmarkPharma Biocon Jubilant Life AurobindoPharma TorrentPh Aventis Pharma Matrix Laboratories Pfizer Ipca Laboratories Ster.54 -0.16 0.74 1968/1030 32729.34 4.94 1844/755 838/188 600/250 728/452 304/199 311/164 373/155 990/326 555/164 42675.05 112.00 1.06 2620.50 346.84 -0.36 56740.90 1873.Company Sales(Rs.90 422.99 17854.Million) Current Price Change (%) P/E Ratio Market Cap.92 70546.27 -2.79 22.05 93.45 286.32 21.75 1289.25 29.79 2.60 612.21 23.28 19251.75 91238.83 320119.29 1.00 841.06 15021.05 316.42 7945.30 11848.00 1815.40 1072.16 1.75 30899.00 271.59 1.Million) 52-Week High/Low Sun Pharma Cipla Dr Reddy's Ranbaxy Labs.15 221.62 7694.00 209.37 24285.03 0.19 16.00 23162.01 21.24 17630.60 16985.89 121845.30 0.89 18.00 41589.65 721.55 344.00 244.12 2.86 18707.85 2863.00 0.57 1546.88 13.27 1.15 611.00 53659.81 1.34 27948.83 351.Biot AstrazenecaPharma Fresenius KabiOncol SunPhaAdv Novartis DishmanPharma Wyeth FDC Strides Arcolab Abbott India 38615.66 1.67 28985.60 8545.90 785.42 5994.99 23.65 175208.32 8310.47 18923.37 227/165 1125/711 304/85 146/90 1109/570 163/42 105/57 633/385 275/136 850/500 96/37 371/98 1210/415 .09 0.84 1.90 2038.04 44.50 15587.85 14.78 15000. 11 21.34 2196.50 990.90 3821.00 42.82 10416.65 2.70 6.81 0.03 1.10 2519.78 0.42 0.28 6181.61 6200.00 26.80 3.35 2696.14 -0.75 3163.30 1060.00 1641.66 22.67 15038.26 4721.89 11.56 2260.85 81.60 193.86 2427.78 8488.67 4290.60 29.75 0.32 14357.50 139.59 2.60 3065.46 4708.69 9.41 14.63 4.96 13.66 3384.72 1.35 1.90 183.17 4731.25 37.56 3.85 3506.61 6455.00 28.62 0.94 3194.77 403.57 3.78 45.11 2.95 3540.60 4465.50 183.40 -2.32 2194.11 2.01 0.19 2.40 12800/2513 2758.00 3.87 3.72 10.00 140.26 6.05 400.46 14.79 4919.12 15.78 3204.08 3.75 6608.45 -2.25 0.57 8.22 1359.62 877.43 2640.25 0.00 112.95 351.66 3704.40 11977.83 7.79 2252.14 12257.35 130.73 2725.40 28.00 10.00 24.03 2.40 47.44 453/189 201/107 3600/650 405/151 248/100 687/371 239/78 44/15 96/37 408/218 363/64 56/35 442/148 184/71 51/15 255/57 139/93 1150/436 12/7 251/100 37/18 152/50 164/35 2873.65 3801.43 2214.33 4.04 9653.95 297.28 6753.09 4.00 58.75 10.10 368.70 173.50 342.40 121.19 13165.47 7229.80 72/18 435/101 196/75 216/82 132/33 312/182 212/73 .31 5.95 635.25 266.00 172.59 29.86 0.69 11.47 1.75 2088.40 7279.15 7.28 1.30 1.24 3864.00 107.10 11914.23 1947.99 0.85 185.00 1.92 1329.25 13.43 7734.95 162.82 3821.74 60. Fulford India Morepen Labs Ankur Drugs Suven Life Sciences Piramal Life Science Sequent Scientific Zandu Realty Shasun Chemicals TTK Healthcare Surya Pharma Alchemist Twilight Litaka Phar Venus Remedies Ajanta Pharma 6568.94 9604.14 3472.15 14.91 2417.68 6767.21 1400.84 11319.Unichem Lab Wockhardt Solvay Pharma PlethicoPharma Panacea Biotec Merck Orchid Chemicals Nectar Lifesciences JB Chem&Pharma Elder Pharma Shilpa Medicare Alembic Indoco Remedies NatcoPharma Bliss GVS Parenteral Drugs Zenotech Lab.55 10940.34 0.67 3.14 2. 03 574.95 111.07 14.37 1144.85 245.00 4.75 17.50 124.02 1028.00 7.00 1912.49 1563.05 39.84 5.50 72.20 43.70 0.Themis Medicare Granules India Amrutanjan Health IndSwiLab Phaarmasia SMS Pharma MarksansPharma Vivimed Labs Jupiter Bioscience Aarti Drugs Anu's Labs Kilitch Drugs Sharon BioMedicine Kopran IndSwiLtd Wanbury AnuhPharma RPG Life Sciences Bharat Immunological Ambal Sarabhai Hester Biosciences Albert David Syncom Healthcare BafnaPharma Adinath Bio-Lab Lyka Labs DIL JagsonpalPharma Neuland Lab.62 1085.92 1995.58 1510.60 2056.45 1277.60 2.97 9.09 1290.28 3765.99 2.80 1727.75 10.42 5870.65 457.68 4.96 4.10 521.80 17.43 3.40 1900.03 1597.70 301/60 115/52 1345/324 80/34 344/253 190/109 8/4 175/65 105/52 128/48 27/5 157/59 144/42 37/9 37/16 96/44 465/172 92/26 26/17 17/10 156/76 143/62 162/39 45/19 21/3 41/17 309/146 27/11 160/92 13/4 66/30 .45 377.91 1186.18 1537.61 1051.12 3.10 301.80 96.02 1.67 10.98 2538.55 45.00 167.35 156.14 12.25 5.86 29.87 494.63 5.20 -4.42 1854.22 1885.60 5834.00 0.19 34.08 8.29 5.14 6.20 94.58 7.90 100.10 29.17 707.35 2.31 2.13 1392.29 1318.00 71.95 9.00 2445.62 1311.41 2.50 253.27 677.00 21.59 0.02 615.95 112.23 -4.41 1014.97 1182.00 0.85 0.26 2.43 71.88 765.25 263.39 1.12 136.50 5.89 1429.32 12.80 18.60 3.14 2.81 1811.85 70.68 1361.10 1.99 218.95 4.35 3.89 785.00 32.75 81.58 478.79 26.40 0.23 3.03 0.62 7.53 2.18 1520.90 5.77 0.22 1642.74 906.00 115.38 0.21 660.05 1.55 1672.92 605.45 7.25 675.94 14.66 3.79 698.05 6.88 1205.30 1514.03 1.00 66.30 -0.30 11.00 10.73 1.47 1.50 613. HiranOrgochem Kerala Ayurveda 1998.35 1.08 625.12 4197.57 713.67 179.29 3.34 501.98 3067. 35 301.35 3.00 2.90 322.00 6.Gufic Biosciences Arvind Remedies Smruthi Organics AhlconParenterals Lincoln Pharma Celestial Biolabs Rubra Medicaments Syncom Formulations Alpa Lab Elder 515.73 105.25 32.68 -1.00 460.50 14.51 10.18 192.55 352.08 6.25 54.01 508.21 575.33 -0.19 4.22 310.76 2178.23 426.65 74.13 1.13 5. Key Products :Maxter .30 1140.34 4.19 0.47 38.64 1201.88 729.55 61.96 0.48 400. It reaches out to interventionists and super-specialty doctors and has also ventured into the field of wound management.92 4.49 0.61 358. Maxter Division emulates the Company¶s objective of µsaving more lives¶.54 378.03 5.22 9.52 5.94 0.85 26. the division was launched in 2006-07.58 5. As a spin-off from Endeavour. with an unwavering focus.75 7.00 11/4 3/1 132/38 58/22 39/19 45/14 59/10 34/15 20/11 111/26 Maxter As the face of Lupin in the critical care segment and AntiInfectives. This division focuses on giving the best therapeutic care in the critical care segment.20 36.50 31. The inception of Maxter has empowered Lupin to tap unexplored opportunities in chosen therapeutic area.36 315.81 390. Product Merotrol Tazar Ceff Cetil Cefantral Product Rank in the Therapeutic segment relevant segment Meropenem Piperacillin + Tazobactam Cephalexin Oral Solids Cefuroxime Oral Solids CefotaximeInjectibles 1 1 3 5 9 PRODUCTS OF LUPIN PHARMA LupinPharma Brand Name Molecule Therapy Segment . 300 MG + ETHAMBUTOL .800 MG + PYRAZINAMIDE .60 MG + ISONIAZID .75 MG +ETHAMBUTOL .300 MG+ ETHAMBUTOL .75 MG + ETHAMBUTOL -275 MG Each tablet contains RIFAMPICIN .60 MG + AKURIT Z KID ISONIAZID -30 MG + PYRAZINAMIDE -150 MG AKURIT KID COMBUTOL 200 COMBUTOL 400 COMBUTOL Each tablet contains RIFAMPICIN .400 MG Each tablet contains TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC .275 MG + PYRAZINAMIDE .150 MG + ISONIAZID -75 MG TUBERCULOSTATIC AKT3 TUBERCULOSTATIC AKT4 TUBERCULOSTATIC AKT FD TUBERCULOSTATIC AKURIT4 TUBERCULOSTATIC AKURIT3 TUBERCULOSTATIC AKURIT TUBERCULOSTATIC Each tablet contains RIFAMPICIN .300 MG Each Kit contains RIFAMPICIN 450 MG + ISONIAZID .AKT 2 Each Kit contains RIFAMPICIN 450 MG+ ISONIAZID .800 MG Each Kit contains RIFAMPICIN 450 MG + ISONIAZID .150 MG+ISONIAZID -100 MG + ETHAMBUTOL .400 MG Each tablet contains RIFAMPICIN .500 MG Each tablet contains RIFAMPICIN .200 MG Each tablet contains ETHAMBUTOL .1500 MG Each tablet contains RIFAMPICIN .150 MG + ISONIAZID .267 MG + PYRAZINAMIDE .30 MG Each tablet contains ETHAMBUTOL .150 MG + ISONIAZID . 600 COMBUTOL 800 COMBUTOL 1000 COMBUNEX ETHAMBUTOL .450 MG Each capsule contains RIFAMPICIN .800 MG Each tablet contains ETHAMBUTOL .450 MG+ ISONIAZID .600 MG Each 5ml containsRIFAMPICIN 100 MG Eah tablet contains RIFAMPICIN .300 MG Each tablet contains RIFAMPICIN .300 MG TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC PYZINAKID PYZINA 500 PYZINA 750 PYZINA 1000 R-CIN 150 MG R-CIN 300 MG R-CIN 450 MG R-CIN 600 MG R-CIN SYRUP R-CINEX 450 MG R-CINEX 600 MG R-CINEX KID R-CINEX Z TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC Eah tablet containsRIFAMPICIN TUBERCULOSTATIC 100 MG + ISONIAZID .1000 MG Each tablet conatins ETHAMBUTOL .500 MG Each tablet contains PYRAZINAMIDE .150 MG Each capsule contains RIFAMPICIN .600 MG Each tablet contains ETHAMBUTOL .300 MG Each capsule contains RIFAMPICIN .600 MG +ISONIAZID .750 MG Each tablet contains PYRAZINAMIDE .100 MG Eah tablet contains RIFAMPICIN TUBERCULOSTATIC .1000 MG Each capsule contains RIFAMPICIN .300 MG Each tablet contains PYRAZINAMIDE .800 MG + ISONIAZID .300 MG Each tablet contains PYRAZINAMIDE . 450+ ISONIAZID .225 MG + ISONIAZID .750MG RCINEX E Eah tablet contains RIFAMPICIN .250 MG Eah tablet contains PROTHIONAMIDE .250 MG Each vial contains KANAMYCIN .500 MG Each vial contains KANAMYCIN .300 MG + ETHAMBUTOL .750 MG Each vial contains KANAMYCIN .100 MG Each vial contains COUGH SUPRESSANT ANTI-INFECTIVES/ ANTI- .225 MG + ISONIAZID .100 MG + ISONIAZID .50 MG + PYRAZINAMIDE ..250 MG PARA-AMINOSALICYLIC ACID Each capsule contains CYCLOSERINE .150 MG + PYRAZINAMIDE .100 MG + ISONIAZID .150 MG +ETHAMBUTOL .50 MG TUBERCULOSTATIC RCINEX EZ TUBERCULOSTATIC RCINEX DT TUBERCULOSTATIC Eah tablet contains RIFAMPICIN RCINEX Z KID .400 MG + PYRAZINAMIDE .800 MG Eah tablet contains RIFAMPICIN .1000 MG TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC TUBERCULOSTATIC Eah tablet contains RIFABUTIN HIV-TUBERCULOSTATIC 150 MG Each pearl contains BENZONATATE .750 MG Eah tablet contains RIFAMPICIN .300 MG RINIZIDE FORTE DT ETHIDE TABLETS PETHIDE Q-PAS CYCLORIN 250 MG EFFICIN 500MG EFFICIN 750MG EFFICIN 1000MG RIBUTIN BENZ E-CEF 125 Eah tablet contains RIFAMPICIN -150 MG + ISONIAZID -100 MG + PYRAZINAMIDE -500 MG Eah tablet contains ETHIONAMIDE . 500MG/100ML BIOTICS Each capsule contains CEFDINIR .500 MG Each vial contains CEFTRIAXONE .1000 MG BIOTICS ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS Each vial contains CEPHALEXIN ANTI-INFECTIVES/ ANTI.125 MG Each vial contains CEFTRIAXONE .MG E-CEF 250 MG E-CEF 500 MG E-CEF 1000 MG ECEF OD CEFTRIAXONE .5 ECEF S 750MG ECEF S 375 MG GCIN LCIN 750 LCIN OZ LCIN IV RTIST 300MG RTIST SUSP NECTERA POWDER DEFNALONE Each vial contains ANTI-INFECTIVES/ ANTILEVOFLOXACIN .250 MG Each vial contains CEFTRIAXONE .250 MG + ORNIDAZOLE .300 MG Each 5ml contains CEFDINIR 125MG/5ML Each 3gm powder contains 500mg COLOSTRUM (28%IgG) 90gm TIN Each tablet conatins ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS NUTRACEUTICAL GLUCOCORTICOID / STERIOD .500 MG ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS ANTI-INFECTIVES/ ANTIBIOTICS ECEF S 1.250 MG BIOTICS Each vial contains CEFTRIAXONE+SULBACTAM 1500 MG Each vial contains CEFTRIAXONE+SULBACTAM 750 MG Each vial contains CEFTRIAXONE+SULBACTAM 375 MG Eah tablet contains GEMIFLOXACIN .320 MG Eah tablet contains LEVOFLOXACIN .750 MG Eah tablet contains LEVOFLOXACIN . U.200 MG MISONIL -200 MISOPROSTOL .U. 150 I.U.3 MG +ETHINYLESTRADIOL .50 MG LUPI-HMG 75IU LUPI-HMG 150IU LUPI-FSH 75IU LUPI-FSH 150IU LUPI-HCG 2000 LUPI-HCG 5000 HUMAN MENOPAUSAL GONADOTROPIN INJ. Hormones Hormones Hormones .U. HUMAN MENOPAUSAL GONADOTROPIN INJ.30 MG NATURAL PROGESTERONE 100 MG NATURAL PROGESTERONE 200 MG GLUCOCORTICOID / STERIOD GLUCOCORTICOID / STERIOD GLUCOCORTICOID / STERIOD Hormones DROSPIRENONE .200 MCG MCG MISONIL -25 MCG FASTRACE MISOPROSTOL . 2000 I. FOLLICLE STIMULATING HORMONE INJ. HUMAN CHORIONIC GONADOTROPIN INJ. HUMAN CHORIONIC GONADOTROPIN INJ.03 MG Hormones MIFEPRISTONE . 75 I. FOLLICLE STIMULATING HORMONE INJ. 150 I.25 MG OVIPHENE-50 CLOMIFENE CITRATE . 5000 I.0.1MG DEFNALONE 6MG DEFNALONE 24MG DEFNALONE 30MG LUPIGEST 100 LUPIGEST 200 YAMINI MEFNIL DEFLAZACORT -1 MG Each tablet contains DEFLAZACORT .U.24 MG Each tablet contains DEFLAZACORT . 75 I.6 MG Each tablet contains DEFLAZACORT .25 MCG PREGNANCY KIT Hormones Pregnancy Detection Hormones OVIPHENE-25 CLOMIFENE CITRATE .U. U.LUPI-HCG 10000 HUMAN CHORIONIC GONADOTROPIN INJ. MindVision Brand Name Stalopam Molecule Escitalopram 5mg Escitalopram 10mg Escitalopram 20mg Therapy Segment Antidepressant Antidepressant Antidepressant Antidepressant Nootropic Nootropic Nootropic Nootropic Antiepileptics Antiepileptics Stalopam Plus Citistar Escitalopram 10mg + Clonazepam 0.10000 I.5mg Citicoline 500mg Citicoline (250mg/ml) Citicoline 500mg (250mg/ml) Citicoline 1000 mg Sustained Release tablets Epilive Levetiracetam 250mg Tablets Levetiracetam 500mg Tablets . MD Olanzepine 5mg Olanzepine 7.5mg Olanzepine 10mg Olanzepine 15mg Arzu Aripiprazole 15mg Aripiprazole 10mg Aripiprazole 30mg Placidin Quetiapine 100mg Quetiapine 200mg Antiepileptics Antiepileptics Antiepileptics Antiepileptics Antiepileptics Antiepileptics Antiepileptics Antiepileptics Antiepileptics Agent for neurpathic pain Agent for neurpathic pain Agent for Neuropathic Pain Agent for Neuropathic Pain Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic Antipsychotic .Levetiracetam 750mg Tablets Lovax Oxcarbazepine 150mg Oxcarbazepine 300mg Oxcarbazepine 600mg Lovax OD Oxcarbazepine 300mg Extended Release Oxcarbazepine 600mg Extended Release Dayo OD Divalproex 250mg Divalproex 500mg Divalproex 750mg Pregadoc Pregabaline 75mg Pregabaline 150mg Pregadoc M Pregabalin 75mg + Mecobalamin 750mcg Capsules Pregabalin 150mg + Mecobalamin 750mcg Capsules Amigold Amisulpride 50mg Amisulpride 100mg Amisulpride 200mg Jolyon . 25mg Tablets Pramipexole 0.5mg Goodnoct XR Zolpidem 6.5mg Extended Release Tablets Tolifast Movexol Tolperisone 150mg Tablets Pramipexole 0.5 mg/mL(20 mL) Other CNS drugs .5mg + Melitracen Anxiolytic 10mg Tablets Edaravone injection 1.25mg Extended Release Tablets Zolpidem 12.Quetiapine 25mg PlaciDox Diazepam 10mg Diazepam 2mg Diazepam 5mg DULOT Duloxetine 20mg Duloxetine 30mg Anxicalm Alprazolam 0.5mg Tablets Pramipexole 1mg Tablets Fibril Fibril SF Ribavin 200 mg Ispaghula husk Ispaghula husk Ribavirin 200mg Ribavirin 50mg Alzidoc Donepezil 5mg Tablets Donepezil 10 mg Tablets Restfull Edastar Antipsychotic Tranquilizers Tranquilizers Tranquilizers Antidepressant Antidepressant Tranquilizers Tranquilizers Hypnotic Hypnotic Muscle Relaxant Drug for Parkinson's Disease Drug for Parkinson's Disease Drug for Parkinson's Disease Laxatives Laxatives Hepatitis C Hepatitis C Drug for Alzheimer's Disease Drug for Alzheimer's Disease Flupentixol 0.25mg Alprazolam 0. Pinnacle For more details on the below given information. kindly visit www.epinnacleworld.com Brand Name TONACT 5 TONACT 10 TONACT 20 TONACT 40 TONACT 80 TONACT PLUS TONACT FORTE TONACT 10MG EZ Molecule Atorvastatin Atorvastatin Atorvastatin Atorvastatin Atorvastatin Atorvastatin + Niacin Atorvastatin + Niacin Atorvastatin +Ezetimibe Therapy Segment Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer . 5MG RAMISTAR 5MG RAMISTAR 10MG RAMISTAR A 2.25 RAMISTAR 2.5 RAMISTAR H 5 RETORLIX 5 RETORLIX 10 RETORLIX 20 RETORLIX 100 RETORLIX injection .TONACT 20mg EZ TONACT TG TONACT 10 MP TRITONACT Atorvastatin +Ezetimibe Atorvastatin + Fenofibrate Atorvastatin Atorvastatin + Fenofibrate + Ezetimibe Atorvastatin + Telmisartan Ramipril Ramipril Ramipril Ramipril Ramipril + Amlodipine Ramipril +Hctz Ramipril +Hctz Torsemide Torsemide Torsemide Torsemide Torsemide Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer + AntiHypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Diuretic Diuretic Diuretic Diuretic Diuretic TONACT-TM RAMISTAR 1.5 RAMISTAR H 2. RETORLIX SP VALENT 40 VALENT 80mg VALENT H VALENT 160 VALENT R PINOM 10 PINOM 20 PINOM 40 MG PINOM H PINOM A 20 MG CLOPITAB 75mg CLOPITAB 150 CLOPITAB A 75 CLOPITAB A 150 CILODOC 50 CILODOC 100 FAXIMAB 10MG/5 ML VIAL Torsemide + Spironolactone Valsartan Valsartan Valsartan + Hctz Valsartan Valsartan +Ramipril Olmesartan Olmesartan Olmesartan Olmesartan + Hctz Olmesartan + Amlodipine Clopidogrel Clopidogrel Clopidogrel + Aspirin Clopidogrel + Aspirin Cilostazol Cilostazol Abciximabinj Diuretic Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Antiplatelet Antiplatelet Antiplatelet Antiplatelet Antiplatelet Antiplatelet Antiplatelet . 5/125 Bosentan mg HARTY Resveratrol + Grape seed extract Pulmonary Anti-Hypertensive Nutritional Supplement Pinnacle CVN (CARDIOVASCULAR NEPHROLOGY) Brand Name ATENOVA 25 Molecule Atenolol Therapy Segment Anti-Hypertensive .LUPENOX 20MG LUPENOX 40MG LUPENOX 60MG PLANEP ISONORM 10 ISONORM 20 ISONORM 30 SR IVABRAD 5MG IVABRAD 7.5/5/10 mg Enoxaparin Enoxaparin Enoxaparin Eplerenone IsosordibeMononitrate IsosordibeMononitrate IsosordibeMononitrate Ivabradine Ivabradine Dobutamine Amlodipine Anticoagulant Anticoagulant Anticoagulant Diuretic Antianginal Antianginal Antianginal Antianginal Antianginal Positive Ionotropes Anti-Hypertensive LUPIBOSE 62.5MG DOFUSE Injection LUPIDIP 2. MG ATENOVA 50 MG ATENOVA 100 MG EZEDOC FRUSELAC FRUSELAC DS ISONORM 10 ISONORM 20 Atenolol Atenolol Ezetimibe Frusemide + Spironolactone Frusemide + Spironolactone IsosordibeMononitrate IsosordibeMononitrate Anti-Hypertensive Anti-Hypertensive Cholesterol Reducer Diuretic Diuretic Anti-Anginal Anti-Anginal Anti-Anginal Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive ISONORM 30 SR IsosordibeMononitrate LIPRIL 2.5mg NEBISTAR 5mg NEBISTAR SA NEBISTAR H Lisinopril Lisinopril Lisinopril Lisinopril + Amlodipine Anti-Hypertensive Lisinorpil + Hydrochlorothiazide Nebivolol Nebivolol Nebivilol + samlodipine Nebivilol + Hydrochlorothiazide Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive STARPRESS XL Metoprolol 100 .5mg LIPRIL 5mg LIPRIL 10mg LIPRIL AM LIPRIL H NEBISTAR 2. STARPRESS XL Metoprolol 25 STARPRESS XL Metoprolol 50 STARPRESS H 25 XL STARPRESS H 50 XL Metoprolol + Hydrochlorothiazide Metoprolol + Hydrochlorothiazide Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive Anti-Hypertensive+Anti-Anginal Anti-Hypertensive+Anti-Anginal Anti-Hypertensive Anti-Hypertensive Anti-Anginal Cholesterol Reducer Cholesterol Reducer Cholesterol Reducer Antiplatelet Antiplatelet STARPRESS AM Metoprolol + XL 30 Amlodipine STARPRESS AM Metoprolol + XL Amlodipine STARPRESS MN Metolprolol + XL 30 Isosorbidemononitrate STARPRESS MN Metolprolol + XL 60 Isosorbidemononitrate STARPRESS R XL 25 STARPRESS R XL 50 RANCAD Metoprolol + Ramipril Metoprolol + Ramipril Ranolazine NOVASTAT 5MG Rosuvastatin NOVASTAT 10MG NOVASTAT 20MG FLETA BOLUS INJ FLETA INFUSION Rosuvastatin Rosuvastatin Eptifibatide Eptifibatide . TIROFUSE LUPIFLO 7.D3 CALCIUM + ZINC + MANGANESE + MAGNESIUM PREPARATION + COPPER ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE Anti-bacterial (CEPHALOSPORIN CALUFT-G CEFAXONE 1000 CEFTRIAXONE IM/IV Mg CEFAXONE 125 Mg CEFAXONE 250 Mg CEFAXONE 500 Mg CEFFOREN CEFTRIAXONE IM/IV CEFTRIAXONE IM/IV CEFTRIAXONE IM/IV CEFDITOREN .5 L LUPIFLO 15 L SENACEPT Tirofiban Recombinant Streptokinase Recombinant Streptokinase Cinacalcet HCL Antiplatelet Fibrinolytic Fibrinolytic Calcimimetic Endeavour Brand Name CALUFT CAPS Molecule Therapy Segment CALCIUM CARBONATE + CALCITRIOL ANTI+ ZINC + MAGNESIUM + BORON OSTEOPOROSIS CALCIUM CITRATE MALEATE + VIT. ORAL) CO-Q-DENT CO-Q-DENT CO-Q-10 CO-Q-10 PHENYLPROPANOLAMINE 25MG + CETIRIZINE 5MG + PARACETAMOL 500MG CETRIZINE CETRIZINE CETRIZINE 5MG + PSEUDOEPHEDRINE 30MG/5ML AMBROXOL 15MG + R-SALBUTAMOL 1MG + GUAIPHENESIN 50 MG + MENTHOL 0.5MG DEXTROMETHORPHAN + CETRIZINE + PSEUDOEPHEDRINE + MENTHOL CEFPODOXIME HERBAL TOOTHPASTE HERBAL TOOTHPASTE COLD PREPARATION ANTI-HISTAMINE ANTI-HISTAMINE COLD PREPARATION COUGH PREPARATION COUGH PREPARATION Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) CZ-3 COLD CZ-3 SYRUP CZ-3 TABLET CZ-COLD CZ-EX CZ-TUS DOXCEF 100 DOXCEF 100 DRY SYRUP CEFPODOXIME DOXCEF 200 CEFPODOXIME DOXCEF 50 DRY SYRUP CEFPODOXIME DOXCEF 50 DT CEFPODOXIME DOXCEFF DT 100 CEFPODOXIME MG . EUBIOZ CAP EUBIOZ SACHET HEPP FORTE SYRUP LUPIN TAZOX 250 MG LUPIN TAZOX 1 GM PREBIOTIC PROBIOTIC COMBINATION PREBIOTIC PROBIOTIC COMBINATION CEFTRIAXONE + TAZOBACTAM CEFTRIAXONE + TAZOBACTAM Gastro-intestinal Gastro-intestinal HAEMATINIC ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE ANTI INFECTIVE INJECTABLE Anti-diarrhoeal Anti-diarrhoeal Anti-diarrhoeal Anti-diarrhoeal Anti-diarrhoeal CEPHALOSPORIN INJ CEPHALOSPORIN INJ CEPHALOSPORIN INJ Anti-bacterial (CEPHALOSPORIN LUPINEM 500 MG IMIPENEM + CILASTATIN MAGNOVA 1G MAGNOVA 250 MG MAGNOVA 5G NIZONIDE NIZONIDE DT TABLET NIZONIDE SUSP NIZONIDE-O NIZONIDE-O SUSP Novapime 1000 mg NOVAPIME 250 MG INJ Novapime 500 mg ODOXIL 125 DT CEFEPIME+TAZOBACTAM CEFEPIME+TAZOBACTAM CEFEPIME+TAZOBACTAM NITAZOXANIDE NITAZOXANIDE NITAZOXANIDE NITAZOXANIDE + OFLOXACIN NITAZOXANIDE + OFLOXACIN CEFEPIME CEFEPIME CEFEPIME CEFADROXIL . ORAL) ODOXIL 250 DT TABLETS ODOXIL 250 PREMIX CEFADROXIL Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) Anti-bacterial (CEPHALOSPORIN ORAL) NEUROTROPIC NEUROTROPIC ORAL ANTIINFECTIVE Anti-peptic Ulcerant Anti-peptic Ulcerant Anti-peptic Ulcerant Anti-peptic Ulcerant Gastro-intestinal Anti-peptic Ulcerant CEFADROXIL ODOXIL 500 Mg CEFADROXIL ODOXIL DS CEFADROXIL ODOXIL OD CEFADROXIL ODOXIL PREMIX CEFADROXIL ODOXIL SUSPENSION OPTINEURON INJ OPTINEURON TABS PERCIN RABLET 10 MG RABLET 10 MG RABLET 20 MG RABLET 20 MG RABLET D caps RABLET I. CEFADROXIL VITAMIN B COMPLEX VITAMIN B COMPLEX PRULIFLOXACIN 600MG RABEPRAZOLE RABEPRAZOLE RABEPRAZOLE RABEPRAZOLE RABEPRAZOLE + DOMPERIDONE RABEPRAZOLE IV .V. SALES (1 RABLET IT RCIFAX RCLONAC TABLET 10 X RESNER INJ RESNER SOFT CAPSULES SIGNOFLAM -P TAB SIGNOFLAM TABLET SOFTOVAC SOFTOVAC SF TOPCERIN ULYSES 150 MG ULYSES 300 MG VIDA-25 VIDA-50 VIDA-H RABEPRAZOLE+ITOPRIDE RIFAXIMIN Gastro-intestinal GI Anti-bacterial (RIFAMPICIN DERIVATIVE) NSAID + APU NEUROTROPIC NEUROTROPIC NSAIDS NSAIDS LAXATIVE LAXATIVE OTHER PLAIN ANTI ARTHRITIC HEPATOPROTECTIVE HEPATOPROTECTIVE ANTI HYPERTENSIVE ANTI HYPERTENSIVE DICLOFENAC SR+ RABEPRAZOLE MECOBALAMINE MECOBALAMINE ACECLOFENAC ACECLOFENAC ISABGOL COMBINATION ISABGOL COMBINATION DIACEREIN URSODESOXYCHOLIC ACID URSODESOXYCHOLIC ACID LOSARTAN LOSARTAN LOSARTAN+HYDROCHLOROTHIAZIDE ANTI HYPERTENSIVE . Lupin Diabetes Care Brand Name Gluconorm SR Gluconorm SR 1g Gluconorm G1 Gluconorm G2 Gluconorm P15 Gluconorm P30 Molecule Metformin 500 mg extended release Metformin 1 gm extended release Metformin 500 mg ER + Glimepiride 1 mg Metformin 500 mg ER + Glimepiride 2 mg Metformin 500 mg ER + Pioglitazone 15 mg Metformin 500 mg ER + Pioglitazone 30mg Therapy segment Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Metformin 500 mg ER + Gluconorm PGPioglitazone 15 mg + Glimepiride 1 1 mg Diabetes Management . 5 mg + Pyri Mecobalamin 750 mcg + ALA 100mg + GLA 60 mg + Benfothiamin Diabetic Neuropathy Management Matilda AF Matilda ER Matilda Inj 1x1ml Misobit 25 Mecobalamin 1500 mcg + Diabetic Neuropathy Management Pyridoxine 20mg + Folic acid 5mg Mecobalamin 500 mcg I.5 mg Lisinopril 5 mg Lisinopril 10 mg Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetic Hypertension Diabetic Hypertension Diabetic Hypertension Lisinopril 5 mg + Amlodipine 5 mg Diabetic Hypertension Lisinopril 5 mg + Hydrochlorothiazide 12.M. Miglitol 25 mg Diabetic Neuropathy Management Diabetes Management .5 mg Mecobalamin 750 mcg + ALA 100 mg+ Pyridoxine 3mg + Folic aci Diabetic Hypertension Diabetic Neuropathy Management Mecobalamin 1500 mcg + ALA 200 Diabetic Neuropathy Management mg + Folic acid 1./I.5 Lipril 5 Lipril 10 Lipril AM Lipril H Matilda Plus Matilda Forte Metformin 1 gm ER + Glimepiride 1mg Metformin 1 gm ER + Glimepiride 2 mg Gliclazide Controlled Release 30 mg Gliclazide Controlled Release 60 mg Glimepiride 1 mg Glimepiride 2 mg Glimepiride 3 mg Glimepiride 4 mg Lisinopril 2.Metformin 500 mg ER + Gluconorm PGPioglitazone 15 mg + Glimepiride 2 2 mg Gluconorm G1 Forte Gluconorm G21 Forte Glutide CR 30MG Glutide CR 60MG Glador 1 Glador 2 Glador 3 Glador 4 Lipril 2.V. Misobit 50 Misobit MD 25 Misobit MD 50 Path 15mg Path 30 mg Path G1 Path G2 Retorlix 5 Retorlix 10 Retorlix 20 Retorlix 100 Retorlixinj Retorlix SP 5 Retorlix SP 10 Starstat 5 Starstat 10 Starstat 20 Starstat 40 Starstat EZ 10 Starstat EZ 20 Telista 20 Telista 40 Telista 80 Miglitol 50 mg Miglitol Mouth Dissolving 25 mg Miglitol Mouth Dissolving 50 mg Pioglitazone 15 mg Pioglitazone 30 mg Pioglitazone 15 mg + Glimepiride 1 mg Pioglitazone 15 mg + Glimepiride 2 mg Torsemide 5 mg Torsemide 10 mg Torsemide 20 mg Torsemide 100 mg Torsemide Injection 10mg/ml Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetic Hypertension Diabetic Hypertension Diabetic Hypertension Diabetic Hypertension Diabetic Hypertension Torsemide 5 mg + Spironolactone Diabetic Hypertension 50 mg Torsemide 10 mg + Spironolactone 50 mg Simvastatin 5 mg Simvastatin 10 mg Simvastatin 20 mg Simvastatin 40 mg Simvastatin 10 mg + Ezetimibe Simvastatin 20 mg+ Ezetimibe Telmisartan 20 mg Telmisartan 40 mg Telmisartan 80 mg Diabetic Hypertension Diabetic Dyslipidemia Diabetic Dyslipidemia Diabetic Dyslipidemia Diabetic Dyslipidemia Diabetic Dyslipidemia Diabetic Dyslipidemia Diabetic Hypertension Diabetic Hypertension Diabetic Hypertension . AM Telmisartan 40 mg + Hydrochlorothiazide 12.RM 5 Telista .Telista H Telista RM 2.5 mg Telmisartan 40 mg + Amlodipine 5mg Diabetic Hypertension Diabetic Hypertension Diabetic Hypertension Diabetic Hypertension Diabetic Neuropathy Management GABASTAR 300 Gabapentin 300 mg GABASTAR SR Gabapentin sustained release 600 Diabetic Neuropathy Management 600 mg GABASTAR M GABASTAR MAX PREGASTAR 75 PREGASTAR 150 Gabapentin 300 mg + Mecobalamin 500 mcg Gabapentin 300 mg + Mecobalamin 500 mcg + ALA 100 mg Pregabalin 75 mg Pregabalin 150 mg Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Neuropathy Management PREGASTAR M Pregabalin 75 mg + Mecobalamin 75 750 mcg PREGASTAR M Pregabalin 150 mg + Mecobalamin Diabetic Neuropathy Management 150 750 mcg DUMORE 20 DUMORE 30 DUMORE 60 DUMORE M 20 DUMORE M 30 DUMORE M 60 RIBAFIT Duloxetine 20 mg Duloxetine 30 mg Duloxetine 60 mg Duloxetine 20 mg + Mecobalamin 750 mcg Duloxetine 30 mg + Mecobalamin 750 mcg Duloxetine 60 mg + Mecobalamin 750 mcg Rimonabant 20 mg Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Neuropathy Management Diabetic Dyslipidemia .5 Telista .5 mg Telmisartan 40 mg + Ramipril 5 mg Telmisartan 40 mg + Ramipril 2. 2mg Vobit 0.3mg Voglibose 0.2 mg Voglibose 0.3 mg Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetes Management Diabetic Dyslipidemia Diabetic Dyslipidemia Diabetic Dyslipidemia LUPSULIN N 40 Recombinant Human Insulin NPH LUPSULIN R 40 LUPSULIN M 30/70 LUPSULIN M 50/50 NOVASTAT 5 NOVASTAT 10 NOVASTAT 20 Recombinant Human Insulin Regular Recombinant Human Insulin 30% Regular & 70% NPH Recombinant Human Insulin 50% Regular & 50% NPH Rosuvastatin 5 mg Rosuvastatin 10 mg Rosuvastatin 20 mg LupinRespira Brand Name BUDAMATE 100 TRANSCAPS(DPI) BUDAMATE 200 TRANSCAPS(DPI) BUDAMATE 400 INHALER(MDI) Molecule Formoterol 6 mcg & Budesonide 100 mcg Formoterol 6 mcg & Budesonide 200 mcg Formoterol 6 mcg & Budesonide 400 mcg Therapy Segment ICS+LABA ICS+LABA ICS+LABA ICS+LABA ICS+LABA ICS+LABA BUDAMATE 100 Formoterol 6 mcg & Budesonide INHALER(MDI)BOX 100 mcg BUDAMATE 400 Formoterol 6 mcg & Budesonide TRANSCAPS (DPI) 400 mcg BUDAMATE 200 Formoterol 6 mcg & Budesonide INHALER(MDI)BOX 200 mcg .Vobit 0. 5mg per 2 ML BUDATE FORTE 4X5X2ML Budesonide 1mg per 2ml BUDATE 3X7X2ML Budesonide.BUDATE 100 DPI BUDATE 100 MDI BUDATE 200 DPI BUDATE 200 MDI BUDATE 400 DPI Budesonide 100 mcg Budesonide 100 mcg Budesonide 200 mcg Budesonide 200 mcg Budesonide 400 mcg ICS ICS ICS ICS ICS ICS ICS ICS ICS+LABA BUDATE 4X5X2ML Budesonide.5mg per 2 ML ESIFLO 125 Salmeterol 25 mcg & Fluticasone INHALER(MDI)BOX 125 mcg ESIFLO 250 INHALER(MDI) BOX ESIFLO500 TRANSCAPS Salmeterol 25 mcg & Fluticasone 250 mcg Salmeterol 50 mcg & Fluticasone 500 mcg ICS+LABA ICS+LABA ICS+LABA ICS+LABA INCS ANTICHOLINERGIC INCS BRONCHODILATOR BRONCHODILATOR BRONCHODILATOR + ANTOCHOLINERGIC BRONCHODILATOR + ANTOCHOLINERGIC BRONCHODILATOR ESIFLOR 100 Salmeterol 50 mcg & Fluticasone TRANSCAPS (DPI) 100 mcg ESIFLOR 250 Salmeterol 50 mcg & Fluticasone TRANSCAPS (DPI) 250 mcg FLUTIFLO IPNEB 15ML MOMEFLO SALBAIR (MDI) SALBAIR TRANSCAPS(DPI) SALBAIR 1 TRANSCAPS(DPI) SALBAIR 1 TRANSCAPS(DPI) SALBAIR 1 FLUTICASONE 50 MCG EACH SPRAY Ipratropium 250 mcg/per ml mometasone 50 mcg in each spray Levo-Salbutamol 50 mcg Levo-Salbutamol 100 mcg Levosalbutamol 100mcg+ipratropium 40 mcg Levosalbutamol 100mcg+ipratropium 40 mcg salbutamol . TRANSPULE SALBAIR 15ML SALBAIR B (MDI)BOX 2,5mg+ipratropium500mcg for 2.5ml salbutamol 5mg/ml levosalbutamol 50mcg+beclomethasone 50mcg BRONCHODILATOR ICS+BRONCHODILATOR SALBAIR B FORTE Levosalbutamol ICS+BRONCHODILATOR TRANSCAPS (DPI) 100mcg+beclomethasone200mcg SALBAIR B levosalbutamol 100+ TRANSCAPS (DPI) beclomethasone 100mcg SALBAIR I (MDI) BOX levosalbutamol 50 mcg+ipratropium 20 mcg ICS+BRONCHODILATOR ICS+ ANTICHOLINERGIC BRONCHODILATOR BRONCHODILATOR ANTICHOLINERGIC ANTICHOLINERGIC ANTICHOLINERGIC + LABA ANTICHOLINERGIC + LABA ANTIHISTAMINE+ INCS DRUG DELIVERY SYSTEM ANTILEUKOTRIENE ANTILEUKOTRIENE ANTILEUKOTRIENE ANTILEUKOTRIENE + BRONCHODILATOR ANTILEUKOTRIENE + ANTIHISTAMINE SALBAIR levosalbutamol 50 mcg TRANSCAPS (DPI) SALBAIR TRANSPULES TIATE DPI TIATE MDI TIOMATE DPI TIOMATE MDI AZEFLO LUPIHALER TELEKAST 4MG TELEKAST 5MG TELEKAST 10 TELEKAST PLUS TELEKASTL salbutamol 2.5mg per 2.5 ml Tiotropium 18 mcg Tiotropium 9 mcg Tiotropium 18 mcg &Formoterol 12 mcg Tiotropium 9 mcg &Formoterol 6 mcg Azelastine 140 mcg + 50 mcg fluticasone each spray Advanced Mono Dose Device Montelukast Sodium Chewable Tablets 4 mg Montelukast Sodium Chewable Tablets 5 mg Montelukast Sodium Tablets 10 mg Montelukast 10 mg &Bambuterol 10 mg Montelukast 10 mg &Levocetirize 5 mg LUDO 120 STERIO 4 STERIO 8 STERIO 16 DOXIFLO 400MG FORMOFLO 125 MDI FORMOFLO 250 MDI FORMOFLO 100 FORMOFLO 250 DUOMATE TRANSCAPS DUOMATE FORTE APTIVATE LCIN 250MG LCIN 500MG LCIN A STARCET 5MG STARCET A STARCET COLD LCF COUGH FORMULA LCF KID MDI Dose Counter Methyl Prednisolone Tablets 4 mg Methyl Prednisolone Tablets 8 mg Methyl Prednisolone Tablets 16 mg Doxofylline tablets 400 mg Formoterol 6 mcg & Fluticasone 125 mcg Formoterol 6 mcg & Fluticasone 250 mcg Formoterol 6 mcg & Fluticasone 100 mcg Formoterol 6 mcg & Fluticasone 250 mcg Formoterol 6 mcg &Beclomathasone 200 mcg Formoterol 6 mcg &Beclomathasone 400 mcg 9 natural ingredients Levofloxacin 250 mg tablets Levofloxacin 500 mg tablets Levocetirizine 5 mg tablets levocetirizine 5 mg+ambroxol 75 tablets DOSE COUNTER ORAL STEROID ORAL STEROID ORAL STEROID BRONCHODILATOR ICS+LABA ICS+LABA ICS+LABA ICS+LABA ICS+LABA ICS+LABA APPITIZER ANTIBIOTIC ANTIBIOTIC ANTIHISTAMINE ANTIHISTAMINE + MUCOLYTIC Levocetrizine 2.5mg+paracetamol ANTIHISTAMINE + 500mg+psedoephradine 60 mg MUCOLYTIC+ANALGESIC Levosalbutamol 1mg+guaiphenesin 50 mg+ambroxol 15mg/5ml Levosalbutamol .5mg+guaiphenesin 50 COUGH FORMULA COUGH FORMULA mg+ambroxol 15mg/5ml INCS ICS LABA INTRANASAL CORTICOSTEROID INHALEDCORTICOSTEROID LONG ACTING BRONCHODILATOR - MARKET SHARE OF LUPIN PHRMA Lupin Q4 & FY 2008-09 Results - Consistent Performance & Solid Growth Q4 2008-09 Consolidated Net Profits up 64.2% at Rs. 1574 million May 13, 2009, Mumbai, India Leading transnational pharmaceutical major, Lupin Limited, reported an outstanding performance for the fourth quarter and financial year ended March 31st, 2009. These audited results were taken on record S. 959 million in Q4 FY 07-08 . Kyowa contributed 12% of the overall revenues .by the Board of Directors at a meeting held in Mumbai today. EU & Japan) increased to 86 % at Rs 5681 million over Q4 FY 07-08 Net profit for Q4 FY 08-09 grew at 64.3 COS. 4424 million 28 ANDAs. 24701 mn Advanced markets sales (including Japan and ANZ) increased to 92% over last year and contributed 50% of the Net Sales for the year as against 36% in the previous year. 18 MAAs.5% to Rs. Lupin¶s Japanese subsidiary.2% to Rs.2% to Rs. South Africa and the Philippines Dividend Announcement of 125 % Key Highlights Q4 FY 08-09 y y y Net sales for Q4 FY 08-09 grew at 39% to Rs. 37759 million from Rs.6%% to Rs. Key Highlights .1574 million compared to Rs.Consolidated FY 08-09 y y y y y y y y y y y y y y Net sales grew at 39.14310 million including API One of the fastest growing generic players in the US by prescriptions and the 9th largest in terms of total prescription base A basket of 22 products in the US with 8 market leaders Domestic Formulations Business grew at 24.6 EDMFs. 3338 mn in previous year (excluding IP income) EBITDA margin increased to 19.7% Exports up by 63. 15 DMFs. 5015 million compared to Rs. 10. Four Major Acquisitions across Germany.2% at Rs. Australia.10434 million. & 1 AU DMF were filed during FY 08-09. 27064 million last year Net profit grew at 50. Advanced Markets sales to US and EU grew at 70% to Rs.Rs.575 million. Advanced markets sales (U. More importantly. Lupin¶s Generic and Branded business recorded exponential growth during the financial year. ³Lupin¶s stellar performance reflects the strong business philosophy guiding us. solid domestic growth & increased activity in all key markets.´ Financials: Advanced markets ± US & Europe Lupin continued its growth momentum in the US and Europe a healthy contribution of 36% to our total revenues at Rs. LPI forged a Strategic Alliance with Forest Laboratories.Commenting on Lupin¶s performance. It has indeed been a year of many achievements and robust growth. Lupin¶s acquisitions have not only consolidated our existing presence in these markets but also leaves us strategically poised to further strengthening our position in the global generics and branded generics market. reported a stellar performance recording sales of Rs.4% as compared to Rs. Inc. the company¶s US subsidiary. . Managing Director. FY 08-09 saw Lupin increasing its product portfolio in the branded generics segment through the launch of AeroChamber Plus®. Lupin has had a very strong year driven by growth and consistent performance across all business segments and markets: a strong business performance in the US. Kamal K Sharma. Dr. said. 13634 million.. 7205 million in FY 07-08. 12563 million reflecting a growth of 74. and we are now strategically poised to not only address market needs but also maintain momentum and direction. (Formulations) USA: Lupin Pharmaceuticals Inc. Lupin Limited. We are in the top 3 market positions by market share in 17 of these products (IMS Jan 09). The brand business contributed 27% to the overall business at USD 74 mn The company further expanded and consolidated on its generic product portfolio with the launches of Ramipril caps. or earlier in certain circumstances. Schering-Plough¶s Clarinex® tablets had U. Divalproex DR tabs. Cefadroxil suspension and caps &Levetiracetam tabs. 500mg. Food and Drug Administration (USFDA). LPI was also recognized by Wal-Mart and awarded its prestigious ³Supplier Award of Excellence´ for the 2nd Quarter 2008 ± which is an acknowledgement of the inroads we have made into the US markets. Lupin Ltd.S. on July 1. out of which 8 are market leaders. During the year. Lupin¶sLevetiracetam tablets are the AB-rated generic equivalent of . Lupin also received the final approval for the Company¶s Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets 250mg. the generic version of Schering-Plough¶s "Clarinex"® tablets. sales of $329 million for the year 2007-MAT June 2008.for marketing and promoting AeroChamber Plus® thereby extending Lupin¶s presence in the respiratory segment and our franchise with Pediatricians which would also additionally open up new offices for Suprax. As per the terms of the settlement. will be licensed under the relevant Desloratadine patents. Commercial shipments of the product have commenced. The Company now has a total of 22 products in the market. Lupin today is one of the fastest growing generic players in the US based on growth in prescriptions and the 9th largest in terms of total prescription base. and free to commercially launch its generic Desloratadine product.S. 750 mg and 1000 mg from the U. according to IMS Health. the company demonstrated its capabilities on the Intellectual Property management front by successfully litigating and settling all ongoing Hatch-Waxman litigation relating to Desloratadine tablets. 2012. Hormosan has been offered to supply Setraline in all 5 regions of Germany covering all AOK-insured persons. Keppra tablets had annual sales of approximately $ 1.UCB Pharmaceuticals¶ Keppra® tablets. based on IMS Health sales data. Hormosan has a strong brand identity in the German generics market through its strong patient compliance message. Lupin also made strategic inroads into the French market by launching CefpodoximeProxetil suspension in Q3.2 billion (USD) for the twelve months ended September 2008. pursuant to § 130a SGB V. We also recorded our first strategic win in the German market through Hormosan in the next two quarters ± having received information on the results of the AllgemeineOrtskrankenkassen (AOK) Tender. essential for patients within the CNS sector. . the Company¶s subsidiary in Japan posted robust net sales of Rs. Europe: Lupin further strengthened its presence in the European Union by completeing its acquisition of HormosanPharma GmbH (Hormosan). AAMLA Japan: Kyowa. a German generics company specialized in the supply of pharmaceutical products for the Central Nervous System (CNS). 4424 mn contributing 12% of Lupin¶s Revenues having grown at over 21 % YoY Our products like Amlodipine ³Amel´ continues to maintain majority market share and Risperidone ³Amel´. indicated as adjunctive therapy in the treatment of certain types of seizures associated with epilepsy. which was launched last year. CefpodoximeProxetil has over 60 % market share in France. PD is ranked number 6 amongst generic companies in South Africa.487 million registering a growth of 24.continue to exhibit market leadership in unit terms. (MC) in Phillipines. ANZ The Company continued its focus on this important market with aggressive filings in Australia. it contributed about 28% of the net sales at Rs 10. This growth was driven by the good performance in the CVS.575 million as against Rs. Inc. 8. MC is a premium branded generics company with a strong position in women¶s health and child care segment. . South Africa Lupin clocked in revenues of Rs 919 million after having acquired an equity stake in Pharma Dynamics (PD) in South Africa in September 08. taking the cumulative MAA filings to 24 till date of which 18 have been approved. The South African Generics Market is currently valued at close to 800 Million USD and growing rapidly Phillipines In March 2009 the Company acquired a majority stake in MulticarePharmaceuticals Phillipines.6% over the previous year. In the current financial year. Pharma Dynamics is one of the fastest growing generic companies in South Africa growing at around 30 % for FY 08-09 with a clear leadership in the cardiovascular segment. Emerging Markets India Domestic Formulations forms a very important part of Lupin¶s overall growth. Research and Development Research & Development has always been a strategic and key focus area for Lupin and this year ± 2008-09 was no exception with 6% of the sales earmarked for R&D and related spends. The divisions catering to branded segments continued to outpace the industry growing over 27%. Lupin also received the final approval for the Company¶s Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets 250mg. The cumulative ANDA filings stood at 90 with 34 approvals granted by the USFDA. Other The USFDA issued a warning letter for the Cephalosporin facility of the Mandideep plant.Diabetes.S. Asthma and Gastro therapy Segments. Lupin has maintained its leadership in Anti-TB segment and has secured a double digit market share in the antiasthma market riding high on the strengths of its offering in this segment. 15 MAAs and two EDMFs during the year. The year 2008-09 was a landmark year with Lupin filing 28 Abbreviated New Drug Application (ANDA) with the USFDA. CNS. . 11 DMFs. Lupin responded to the observations in December and provided corrective actions for each of the responses. The facility was inspected in November. 500mg. 750 mg and 1000 mg from the U. Food and Drug Administration (USFDA) during the quarter. The warning letter was issued to provide Lupin with an opportunity to submit additional documentation and explanation to a few selected observations where the FDA felt that the initial responses were inadequate and could be strengthened by further evidence of compliance with enhanced documentation practices. 2008 for a routine GMP inspection. As a result Lupin had received 15 procedural observations. Licensing and acquisitions. Please contact us regarding business or product collaboration opportunities . We strive for continued growth and are avidly interested in learning about prospective opportunities in the specialty pharmaceutical market. Our success is tied to continually meeting the need for basic products to promote human health. Lupin is also seeking to be the partner of choice for product development. 12.All products maintain their approved status. COMPANY MANUFACTURING/R&D Business Development Lupin was founded to meet the very basic need for effective treatment of tuberculosis.50 per equity share of the face value of Rs. Dividend-In view of excellent performance. 10 each. Our API business unit is seeking partners for Lupin developed API's. Lupin manufacturing will not be disrupted and it will continue to provide quality products to customers without interruption.eRs. We are also open to collaborating to develop innovative products formulated with Lupin¶s drug delivery and taste masking technology. the Board of Directors recommended a dividend of 125 % i. We expect our products to come from: y y y In-house product development. Marketing alliances. Our company strives to bring important new products to market each year. Our scientists apply know how and expertise to develop NCE¶s or to solve difficult formulation challenges. Lupin has formulated a strategy to address and resolve the USFDA and is confident of being able to satisfy the USFDA¶s observations expeditiously. reinforcing our ability to submit high quality dossiers and gain on time approvals. from process development of the API to the submission of dossiers for finished dosages.Phone: 410-576-2000 Facsimile: 410-576-2221 Email: [email protected]. Six of Lupin's 14 ANDA approvals were the first granted by the US FDA. entered the U. generic pharmaceutical market in 2003 with the ANDA approval for cefuroxime axetil.com NEW Products Generics Lupin Pharmaceuticals. Expanding the product portfolio. Inc. Our integrated manufacturing capability provides a portfolio of the highest quality generic products. We are vertically integrated. Lupin . Since then we have received more than a dozen FDA approvals. This provides control over the supply chain and the ability to offer quality products at the right time and at competitive prices. Our oral and injectable cephalosporin facilities. 2010 capsules View . is geared to file 15 or more ANDA¶s per year in some of the following areas: Oral and injectable cephalosporins. Paragraph IV¶s. Newsroom Lupin receives FDA approval for Imipramine Pamoate Capsules View Apr 16. Inc. Cardiovascular. 2010 Lupin receives FDA tentative approval for Eszopiclone tablets View Mar 20. allow us to file and manufacture a wide range of finished products for the US market. 2010 Lupin receives FDA approval for Amlodipine/Benazepril Feb 08.Pharmaceuticals. Controlled release ANDA¶s. US FDA approved manufacturing sites and the new tablet and capsule facility in Goa. 2010 Lupin receives FDA tentative approval for MemantineHCl Jan 19. 2009 Lupin Receives ³Supplier Award of Excellence´ from Wal-Mart View Sept 17. 2008 Lupin receives USFDA approval for Divalproex Sodium Delayed-Release Tablets View July 29.Lupin receives FDA approval for Perindopril Erbumine Tablets View Jan 28. 2010 tablets View Lupin is granted USFDA approval for Levetiracetam Tablets View Jan 16. View June 26. . 2008 Lupin Enters Into Marketing Alliance with ASCEND June 23. 2008 Lupin appoints New NCE Research Head. 2008 View Lupin Receives ³Best New Manufacturer of the Year´ Award from AmerisourceBergen View July 30. 2007 Lupin receives final approval for Amlodipine Tablets View July 12. 2008 Lupin receives USFDA approval for Topiramate Tablets May 29. View 2008 Lupin receives USFDA approval for Escitalopram Oxalate Tablets View June 16. 2008 Lupin launches Ramipril capsules View June 10. 2007 Lupin announces Final Approval of Trandolapril Tablets June 13.Therapeutics for SUPRAX® 400 mg Tablets in the U. 2007 View .S. of Suprax® Suspension 2007 View Lupin Receives US FDA Approval for Sertraline.Lupin Receives US FDA Approval for ZiprasidoneHCl Capsules View May 22. Launches Entire Product Family. 2007 Products . View May 8. View February 7. 2007 Lupin Announces Final FDA Approval of Cefdinir for Oral Suspension. 2007 Lupin Receives US FDA Approval for Novel Formulation April 12. 250 mg/5 mL. Suprax® is now available in tablets and suspension formulations. is committed to developing a branded pharmaceutical presence for pediatric practice in the US market.. Inc. developing and marketing prescription drugs for children of all ages. Inc. has an exclusive license in the United States to use the Suprax® trademark. Inc. Lupin Pharmaceuticals. Our focus is on in-house product development with our proprietary oral controlled release and taste masking platforms. Lupin has created a dedicated national sales force to call upon pediatricians. Inc. We plan to expand our family of pediatric products to help meet needs of children.. Lupin Pharmaceuticals. is also open to marketing alliances. is very pleased to offer Suprax®. and to licensing/acquisitions. Lupin Pharmaceuticals. an important anti-infective product in pediatric and other physician practices within the United States. We are committed to identifying. API .Specialty A commitment To Caring For Kids Lupin Pharmaceuticals. Diabetology. puts the company in a very strong position to offer a diverse portfolio of niche API¶s to its customers. The Company is the world¶s largest manufacturer of Tuberculosis drugs. synthetic process development and fermentation skills coupled with its intellectual property strengths. with FDA approval to manufacture complex oral and injectable cephalosporins. SHARE IN MARKET ANNUL Lupin Limited (NSE:EQLUPIN) Lupin Limited is amongst the top six pharmaceutical companies in India in terms of revenue. India Lupin Limited is a transnational pharmaceutical company producing generic and branded formulations and Active Pharmaceutical Ingredients(APIs)[1]The Company has secured global leadership position in Anti-TB and Cephalosporins and has a significant presence in the areas of Cardiovasculars (prils and statins).Lupin is recognized as a leading manufacturer of cephalosporin API¶s. Lupin is fast gaining share in the cardiovascular segment manufacturing a wide range of ACE-inhibitors and cholesterol reducing agents. Asthma and NSAIDs(Non-steroidal anti-inflammatory drugs)[1] . Business Overview Headquartered in Mumbai. Lupin¶s capabilities in sterile processing. 2% at Rs.48%NRI's/OCB's/Foreign Others2.[1] Business and Financial Metrics Lupin Limited's share holding pattern [4] Entity Percentage Indian Promoters 50. and Insurance09.76%Private Corporate Bodies1.15% General Public9.90%Others0.13% Business Segments Formulations Active Pharamceutical Ingredients and Intermediates ROCE is comparable to the best in the segment at 33%[6] \ .01% FII's 11.21%Banks Fin.62% Foreign Promoters 0.Net profit for Q4 FY 08-09 grew at 64. 1574 million compared to Rs 959 million in Q4 FY 07-08.Net sales growth for Q4 FY 08-09 was 39% at Rs. 10434 million. Inst. 1 in India in speciality therapy areas like psychiatry.It is a global pharmaceutical company with it's headquarters in India and a presence in more than 100 countries.The industry is therefore led by large manufacturers and marketers of drugs investing heavily in research & development. Sun Pharmaceutical Industries Inc (subsidiary)[8] [9] Cipla . having clinical testing. diabetology and respiratory. cardiology.Cipla is a leader in the domestic retail pharmaceutical market.It is No.Competition The pharmaceutical industry is characterized by rapid advances in scientific knowledge and ability to discover new drugs.[12]In India it the biggest drug maker by sales[13] Comparison with the competitors: .[9] GlaxoSmithKline . and veterinary products to some 180 countries around the world. 1500 crore is one of the market leaders(market share) in India with a share of 6. intermediates.S.2 per cent infectives.It has brands in 30 markets worldwide and also has a generic presence in the U. marketing and distributing capabilities[7]. with Caraco Pharm Labs.Some of the main competitors of Lupin are: Sun PharamceuticalsIndustires . It also exports raw materials. Reddy's Laboratories . dermatologicals and pain management drugs [11] [10] Its main portfolios consists of anti- Dr. prescription drugs.It is one of the oldest pharma companies in India and with a turnover of Rs. gastroenterology. over-the-counter products. neurology.[8]. [15] .428.35 4.427.947.57 475.Financial metrics FY2008 Name Lupin Sun Pharma Cipla Yr Ended Market Capitalization in Rs Cr Sales Turnover in Rs Cr Net Profit in Rs Cr Mar '08 6.992.66 9.64 3.22 GlaxoSmithKline Dec '07 DrReddys Labs Mar '08 9.293.87 Mar '08 17.43 576.662.40 443.95 1.41 2.661.473.62 2.04 701.42 Mar '08 26.762.38 1.975.53 Market Share on the basis of Retail Sales Due to high level of fragmentation none of the Pharma Companies had more than 6% of the total market on the basis of the total retail sales.014. . Inc. Inc. Lupin Pharmaceuticals. announced that it has been granted final . Gets US FDA Nod for Anti-Depressant 04/20/2010 Lupin Pharmaceuticals.KEY DEVELOPMENTS FOR LUPIN PHARMACEUTICALS. INC. The product will be introduced in the market through LPI's strong network of national wholesalers and pharmacy chains post patent expiry in 2012. 2009. The drug is recommended for relieving depression symptoms. The drug had an annual sales of about $39 million for the year ended December. Lupin Receives FDA Tentative Approval for Eszopiclone Tablets 03/22/2010 Lupin Pharmaceuticals. Food and Drug Administration (USFDA). The company's Eszopiclone tablets are the ABrated generic equivalent of Sepracor's LUNESTAR tablets. 1 mg. 125 mg and 150 mg. The brand product had annual sales of approximately $761 million for the twelve months ended December 2009. Lupin's Imipramine Pamoate capsules are generic equivalent of Mallinckrodt's Tofranil-PM. 2 mg and 3 mg from the U. 100 mg. based on IMS Health sales data. in a patent dispute over the oral solution of the antibiotic Cipro. Bayer AG Sues Lupin Pharmaceuticals in Patent Dispute over Oral Solution of the Antibiotic Cipro 03/9/2010 Bayer AG is suing Lupin Pharmaceuticals. announced that it has received tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Eszopiclone tablets.S. Inc.approval from the Food and Drug Administration (FDA) for the capsules in strengths of 75 mg. indicated for the treatment of insomnia. Inc. Lupin informed Bayer Schering Pharma and Bayer HealthCare Pharmaceuticals that it had filed an ANDA to manufacture a generic Cipro (ciprofloxacin) oral solution in 250 mg/5 mL and 500 mg/5 mL strengths before patent protection ends .